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Diseasealpha-proteobacteria captured within a host between two and three billion years
ago. This origin resulted in the formation of a double-layered organelle resulting in four distinct sub-
compartments: the outer membrane, the intermembrane space, the inner membrane and the matrix. The
inner membrane is organized in cristae, harboring the respiratory chain and ATP synthase complexes
responsible of the oxidative phosphorylation, the main energy-generating system of the cell. It is generally
considered that the ultrastructure of the inner membrane provides a large variety of morphologies that
facilitate metabolic output. This classical view of mitochondria as bean-shaped organelles was static until in
the last decade when new imaging studies and genetic screens provided a more accurate description of a
dynamic mitochondrial reticulum that fuse and divide continuously. Since then signiﬁcant ﬁndings have
been made in the study of machineries responsible for fusion, ﬁssion and motility, however the mechanisms
and signals that regulate mitochondrial dynamics are only beginning to emerge. A growing body of evidence
indicates that metabolic and cellular signals inﬂuence mitochondrial dynamics, leading to a new
understanding of how changes in mitochondrial shape can have a profound impact on the functional
output of the organelle. The mechanisms that regulate mitochondrial morphology are incompletely
understood, but evidence to date suggests that the morphology machinery is modulated through the use of
post-translational modiﬁcations, including nucleotide-binding proteins, phosphorylation, ubiquitination,
SUMOylation, and changes in the lipid environment. This review focuses on the molecular switches that
control mitochondrial dynamics and the integration of mitochondrial morphology within cellular signaling
cascades.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionMitochondrial morphology is tightly regulated by balanced
fusion and ﬁssion events. These processes require several factors,
many of them conserved during evolution. The fundamental
importance of maintaining a highly dynamic mitochondrial reticu-
lum is demonstrated by the essential nature of most of the proteins
described in this section. Mice lacking the core fusion machinery are
embryonic lethal, and there are a number of human diseases caused
by mutations in both the fusion and ﬁssion proteins (reviewed in
[1]). In the ﬁrst section, we will introduce the machinery that has
been characterized through the use of genetic and biochemical
screens in multiple experimental model systems (Fig. 1). The second
section of this review will expand upon the physiological impor-
tance of mitochondrial dynamics, and how these processes are
integrated within cellular signaling pathways (Fig. 2).613 761 5281.
Bride).
l rights reserved.2. Machineries that govern mitochondrial dynamics
2.1. Mitochondrial fusion machinery
2.1.1. Outer membrane fusion machinery
The central components of the mitochondrial fusion machinery
include the mitofusin GTPases. Mammals have two Mitofusin homo-
logues, namely Mfn1 and Mfn2, that are anchored in the mitochon-
drial outer membrane, while Fzo1 (Fuzzy Onion 1) is the single yeast
orthologue [2]. These large, dynamin-like proteins contain an N-
terminal GTPase domain and two coiled-coil domains both exposed to
the cytosol [3,4]. Examination of the structure of the heptad repeats
within Mfn1 suggests that Mfn1 tethers mitochondria by forming
coiled-coil interactions with another Mfn1 protein in trans [5]. Data
from isolated yeast mitochondria have shown that fusion requires GTP
hydrolysis, suggesting that nucleotide hydrolysis by trans-paired Fzo1
may drive mitochondrial fusion forward [6]. AlthoughMfn1 and Mfn2
can form homo and hetero-oligomeric complexes and have partially
overlapping functions [7], recent evidence suggests that Mfn2 may
have evolved additional, more specialized roles relative to Mfn1 or
Fzo1 [8]. For example, the GTPase activities of the two mitofusins are
different, with Mfn1 possessing very fast rates of hydrolysis and low
afﬁnity for nucleotide, consistent with a dynamin-like function,
Fig. 1. Integration of mitochondrial dynamics within cellular signaling cascades. Evidence described within the text indicates that the activation of mitochondrial ﬁssion, fusion and
motility can be regulated by cellular cues. The example shown in (1) refers to conditions of hyperglycemia where the uptake of glucose leads to the activation of Drp1 and
mitochondrial ﬁssion. In (2), the long-range motility requires the action of kinesins, dyneins, Milton and Miro, and has been shown to be regulated by calcium. The regulation and
activation of these proteins on the mitochondrial surface is not yet clear. In (3), the transition of mitochondria from long-range movement along microtubules to short range
movement, or the anchoring of mitochondria to the actin cytoskeleton upon activation of TrkA receptors occurs in a PI(3)kinase-dependent manner. In another example, the NMDA
receptor dependent movement of mitochondria into dendritic spines has been shown to involve the activity of WAVE1, which recruits the Arp2/3 complex to the mitochondria,
thereby driving the production of actin ﬁlaments on the surface. Finally, in (4), mitochondria at their anchored destination fulﬁll important, cell type speciﬁc functions, including the
production of ATP for the myosin driven movement of T-lymphocytes, the buffering of calciumwithin neuronal and immunological synapses, etc. See text for more examples of the
regulation of these mitochondrial transitions in morphology and position.
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afﬁnity for nucleotide [9,10], which is consistent with the more
regulatory GTPases. An elegant in vitro tethering assay demonstrated a
signiﬁcantly enhanced role for Mfn1 in driving mitochondrial
tethering relative to Mfn2, further highlighting their potentially
unique contributions to mitochondrial docking and fusion [9]. In
addition, the creation of a hydrolysis deﬁcient mutant of Mfn2 led to
the observation that GTP-bound Mfn2 stimulated mitochondrial
fusion, which indicates that hydrolysis of GTP by Mfn2 is not required
for mitochondrial fusion [10]. The stimulation of fusion while in the
GTP-bound form is instead consistent with a role as a regulatory
GTPase. Whether the nucleotide states of Mfn1 and Mfn2 are
regulated by exchange factors or GTPase activating proteins is
unknown, but future experiments will help to shed light on the
functional role of their GTP switches. In addition to their roles in
mitochondrial fusion, several lines of evidence suggest that the two
mitofusins are also essential during development, in the progression
of apoptosis, and in disease [8]. For example, the loss of bothMfn1 and
Mfn2 results in embryonic lethality, however the loss of Mfn2 leads to
a defect in placental implantation, whereas the loss of Mfn1 results in
embryonic lethality a day or two later [7]. In conditional knock-out
mice, Mfn2, but not Mfn1, was required for dendrite growth and spine
formation, and the loss of Mfn2 led to the death of Purkinje cells [11].
These animal models show that Mfn1 and Mfn2 have distinct
physiological roles and may begin to explain why only mutations in
Mfn2 have been found in human disease like Charcott-Marie Tooth
type 2A or autosomal dominant optical atrophy (reviewed in [12]).
The identiﬁcation of new binding partners for the mitofusins that
demonstrate nucleotide speciﬁcity would also help to uncover the
mechanisms that regulate mitochondrial fusion. Some binding
partners have been identiﬁed, however their nucleotide speciﬁcity is
not always clear. One regulator of the activity of the mitofusins has
been identiﬁed as Mitofusin-binding protein (MIB), a cytoplasmic
member of the medium chain dehydrogenase/reductase protein
superfamily [13]. The function and localization of the proteins ofthis superfamily are largely unknown. MIB was shown to interact with
bothMfn1 and Mfn2 but the regulation of the targeting mechanism of
MIB to the mitochondria remains to be elucidated. Overexpression of
MIB led to mitochondrial fragmentation, by inhibiting Mfn1 activity
[13]. In addition, MIB regulation of mitochondrial morphology
requires the functional coenzyme-binding domain (CBD). The mod-
ulation of MIB activity appears to be essential for cell growth but not
for apoptosis. It was hypothesized that the CBD domain of MIB could
recognize the GTP-bound form of mitofusins, thus controlling the
GTPase activity in a manner linked to the dehydrogenase activity of
the enzyme, but this has not been tested directly.
Crosslinking and immunoprecipitation experiments identiﬁed that
stomatin-like protein2 (Slp-2) interacts with Mfn2 [14]. Slp-2 is a
mitochondrial protein that is processed upon import and remains
associated with the inner membrane, facing the intermembrane space
[14]. It was shown to also bind prohibitins and play a role in their
stability, along with that of other proteins including complexes I and
IV [15]. As a member of the stomatin and prohibitin/ﬂotillin family of
proteins, Slp-2 is also incorporated within cholesterol enriched
microdomains [16–18]. Higher expression levels of Slp-2 have been
associated with increased cellular proliferation, and it is emerging as a
new marker for more aggressive cancer, however the links between
these phenotypes and the mitochondrial function of Slp-2 are
unknown [19–21]. Knockdown of Slp-2 showed a slight decrease in
mitochondrial potential but did not induce a dramatic change in
mitochondrial morphology, indicating that this protein is not essential
for mitochondrial fusion [14]. It is not yet known if this interaction can
functionally modulate Mfn2 activity, or how it may bind Mfn2 from its
intermembrane space location. Further work is needed to determine
the importance of this interaction in the regulation of mitochondrial
dynamics.
Genetic screens in yeast identiﬁed additional proteins required to
maintain mitochondrial morphology and distribution, and some of
them appear to be conserved during evolution where others have no
obvious mammalian counterpart. Ugo1p (Ugo means fusion in
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component for mitochondrial fusion [22]. Nomammalian orthologues
have been identiﬁed to date. It is a multipass transmembrane protein
of the outer membrane containing a putative carrier domain and is
found in a protein complex with both Fzo1 and the inner membrane
GTPase Mgm1 (see below) [23–25]. This led to the speculation that
Ugo1may be an adaptor connecting these two GTPases in order to co-
ordinate the fusion of the outer membrane with the initiation of
Mgm1-mediated inner membrane fusion.
Regulation of mitochondrial fusion depends not only on protein
complexes but also on changes in membrane properties. In mammals,
an outer membrane, mitochondrial-anchored phospholipase D pro-
tein, MitoPLD, has been shown to be required for mitochondrial fusion
[26]. The enzymatic activity of MitoPLD is localized to the cytosolic
surface of the organelle where it hydrolyses cardiolipin to generate
phosphatidic acid (PA), a fusogenic lipid. The role of PA in
mitochondrial fusion is still undetermined; although it appears to
function at a point after Mfn1/2-dependent tethering since its
silencing leads to docked mitochondria that cannot fuse [26]. The
local changes in lipid composition at a site of docking may alter the
membrane curvature to facilitate fusion of opposing membranes, or
recruit additional factors that may participate in this process.
2.1.2. Inner membrane fusion machinery
Mitochondrial fusion is a complex reaction due to the presence of
two membranes that require the existence of two distinct machi-
neries. In vitro fusion assays using mitochondria isolated from yeast
cells revealed that the two fusion events are distinct and have
different energy requirements [6,27]. The large GTPase OPA1 (Optical
Atrophy 1), or Mgm1 (mitochondrial genome maintenance) in yeast,
plays an essential role in mitochondrial inner membrane fusion [2].
Mgm1 and OPA1 are found in the intermembrane space associated
with the inner membrane and their function is linked to that of Fzo1
and Mfn1 respectively [23,24,28]. OPA1, but not Mgm1, is present in
eight mRNA splice forms that can undergo proteolytic processing in
mitochondria, producing a complex mixture of long and short OPA1
forms [29]. Recently, it has been clariﬁed that the presence of both
long and short OPA1 orMgm1 products is important for mitochondrial
fusion activity [30–35]. Early studies demonstrated that Mgm1 is
cleaved by Pcp1/Rbd1 (protease of cytochrome c peroxidase 1/Rhom
boid protease 1), a rhomboid protease localized in the inner
membrane [30–32]. The balance between the two cleaved forms of
Mgm1 is governed by amechanism called alternative topogenesis that
depends on the mitochondrial import motor and on the matrix ATP
level [36]. It has been suggested that this mechanism may prevent
mitochondria presenting unfavorable bioenergetics from fusing into
the rest of the mitochondrial network [33,36].
Although the function of OPA1 and Mgm1 in regulating mitochon-
drial fusion is conserved, OPA1 processing appears to have evolved
quite differently. Understanding the identity and regulation of the
proteases that cleave OPA1 has beenmade technically challenging due
to the fact that there are two proteolytic sites S1 and S2 within the 8
splice variants which generate a number of short isoforms. Perhaps it
is not surprising then that the identity of the protease activated in this
condition is currently the subject of intense investigation and some
controversy. Several studies have demonstrated that the rhomboid
protease PARL, the mammalian orthologue of Pcp1, is not the primary
protease that cleaves OPA1 at S2 [37]. Instead, it appears that
mitochondrial AAA proteases are involved in this process. The i-AAA
protease Yme1L appears to be a central protease responsible for OPA1
cleavage at the S2 site [34,35,38], although it is also possible that
matrix-AAA proteases and prohibitins contribute to this process [39–
41]. The reason for this evolutionary change in themechanism of OPA1
cleavage is not yet understood. However while the metabolic status of
the mitochondria determines the topology of Mgm1 during import,
OPA1 cleavage at the S1 site and the degradation of the long forms isstimulated upon the loss of electrochemical potential, and during
apoptosis [33,38]. This may reﬂect an improvement in the respon-
siveness of mammalian mitochondria to damaging cellular triggers
relative to yeast.
2.1.3. Regulation of the mitochondrial fusion machinery
The list of proteins that function as core machinery in the fusion
reaction remains relatively short. However, there are a number of
other proteins implicated in the fusion reaction that likely play a more
regulatory role. These proteins modify the function or protein levels of
the core machinery and are described below.
Ups1 (Unprocessed 1) is a yeast mitochondrial intermembrane
space protein peripherally associated with the inner membrane [42].
Ups1 regulates the alternative topogenesis of Mgm1p in the inner
membrane but is not part of the protein import machinery. Ups1
expression is required for the formation of the short, cleaved form of
Mgm1p when cells are grown in the fermentable carbon source
glucose. This regulation by Ups1 was not observed when cells are
grown on non-fermentable carbon source. The speciﬁc requirement
for Ups1 suggests that this protein is essential to assume control of
mitochondrial dynamics under certain metabolic conditions. PRELI
(protein of relevant evolutionary and lymphoid interest) is the human
orthologue of Ups1 [43]. When expressed in ups1Δ yeast cells, PRELI
was efﬁciently targeted to the mitochondria and functionally rescued
the ups1Δ phenotype, indicating that the function of Ups1 is
evolutionarily conserved among eukaryotes [42]. The mechanism of
action of Ups1 will require further investigation.
Another protein, Mdm38 (mitochondrial distribution and mor-
phology 38), has been identiﬁed from genetic screens in yeast [44],
and its mammalian orthologue is called LETM1 (1eucine zipper-, EF-
hand-containing transmembrane protein 1) [45]. Mutations in LETM1
lead to Wolf–Hirschhorn disease, a devastating condition marked by
severe growth retardation and epileptic seizures, generally leading to
early death [46,47]. LETM1 is an inner membrane anchored protein
containing two calcium-binding EF-hand motifs, a leucine zipper and
several coiled-coil domains [46]. Loss of LETM1 leads to a fragmented
and swollen mitochondrial phenotype. Recent experiments have
shown that LETM1 plays a critical role in the exchange of K+ for H+
across the inner membrane, and therefore controls ion homeostasis
[48,49]. The loss of this protein leads to an inﬂux of water, which likely
explains the swollen phenotype. Addition of nigericin, a K+/H+
ionophore, rescued the swelling and restored mitochondrial fusion
in cells lacking LETM1 [49]. An alternative role as been proposed from
a study showing thatMdm38 functions as a component of an insertion
machinery in the inner membrane of certain mitochondrially encoded
proteins [50]. Therefore, although Mdm38/LETM1 is required for the
maintenance of mitochondrial morphology, the impact of this protein
on the fusion machinery is likely indirect.
Factors regulating the core outer membrane fusion machinery
have also been identiﬁed. Mdm30p is a yeast member of the Skp1-
Cullin-F-box (SCF) ubiquitin ligase family, a family known to play a
role in the regulated turnover and degradation of a number of cellular
proteins. Consistent with this, Mdm30p was shown to play a role in
mitochondrial fusion by controlling the turnover of Fzo1 in vegetative
growing cells [51]. The loss of Mdm30 leads to mitochondrial
aggregation and a failure to respire [51,52]. It was subsequently
shown that Mdm30 is required to bind to Fzo1 and mediates its
degradation [52,53]. Mdm30-dependent turnover of Fzo1 during
vegetative growth was initially shown to occur even upon inactivation
of the proteasome and/or the vacuole, indicating the presence of an
unidentiﬁed mechanism for Mdm30-dependent mitochondrial outer
membrane protein turnover [53]. However, more recently, it was
shown that Mdm30 mediated degradation of Fzo1 during vegetative
growth did depend upon the Skp1-Cullin-F-box (SCF) ubiquitin
ligases, and the targeting of Fzo1 to the 26S proteasome [52].
Interestingly, Fzo1 mediated turnover through the proteasome
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independent [54], suggesting more than one mechanism for the
regulation of Fzo1 turnover depending on the state of cellular growth.
The regulation of Mdm30 activity and the signals that drive Fzo1
ubiquitination will ultimately reveal important crosstalk between the
triggers of cellular growth and mitochondrial morphology.
Interestingly, Mfb1 (mitochondria-associated F-box protein) is
another yeast mitochondria-associated F-box protein, which is also
required to maintain mitochondrial morphology [55,56]. Although
yeast cells lacking Mfb1 are fusion competent, their mitochondria
become slightly fragmented. During yeast cell division, Mfb1 remains
within the mother cell and does not target the mitochondria within
the bud, providing evidence of its asymmetric distribution during the
cell cycle. The presence of two distinct F-box proteins on the
mitochondria supports the idea that ubiquitination andmitochondrial
protein turnover play important roles in the regulation of mitochon-
drial dynamics and cell cycle transition. The characterization of their
targets will be an important goal of future experiments.
Recently Okamoto and co-workers reported that two of the TOM
mitochondrial import receptors (Translocase of the OuterMembrane),
Tom70 and Tom71, recruit Mfb1 to the mitochondrial surface [57].
Proteins of mitochondrial import machineries have already been
implicated in the mitochondrial morphology and distribution
(reviewed in [58]). This is perhaps not surprising given that
impairment of mitochondrial import activity could have secondary
effects on the import of components that regulate mitochondrial
morphology. A typical example is the role of the mitochondrial import
motor and the alternative topogenesis of Mgm1 [36]. Also in yeast, the
import of the mitochondrial morphology protein Mdm35 requires the
MIA pathway (mitochondria import and assembly), the speciﬁc
machinery for import and assembly of intermembrane space proteins
[59]. Nevertheless, it cannot be excluded that some factors of
mitochondrial import may have a dual role and could inﬂuence the
shape of the organelle. These factors would orchestrate the crosstalk
between mitochondrial biogenesis and morphology by recruiting and
modulating the activity of the morphology machinery.
In summary, there are a number of factors that have been
identiﬁed as components of the mitochondrial fusion machinery.
These represent the starting point to continue our exploration of the
mitochondrial fusion reaction, including the molecular mechanisms
that deﬁne mitochondrial docking, the formation of the fusion pore
and bilayer mixing. The cellular regulation of fusion and the co-
ordination of outer and inner membrane fusion are of critical
importance for us to complete this very intricate cell biological puzzle.
2.2. Mitochondrial ﬁssion machinery
2.2.1. Outer membrane ﬁssion machinery
The central player that mediates mitochondrial ﬁssion is the
mitochondrial dynamin-related protein, Drp1, or Dnm1 in S. cerevisiae
[2]. Drp1 is a cytosolic protein that is recruited to the mitochondrial
outer membrane where it oligomerizes into ring-like structures that
constrict the organelle in a GTP-dependent manner [60]. Drp1 forms
punctate foci on the mitochondria but the mechanism of initial Drp1
recruitment is largely unknown. These punctate foci of Drp1 appear to
migrate towards a site of mitochondrial ﬁssion, where they assemble
into a functional scission complex. As predicted from its homology to
Dynamin 1, the yeast Dnm1 has been shown directly to form
oligomeric ring-like structures that require GTP hydrolysis for
constriction and disassembly [60]. A second mitochondrial ﬁssion
protein, called Fis1 (Fission protein 1) was originally identiﬁed as an
essential ﬁssion protein fromyeast genetic screens [61]. Fis1 is a small,
integral membrane protein containing a cytosolic exposed tetratrico-
peptide repeat domain which mediates protein interactions. Fis1 is
required for yeast Dnm1 recruitment to the mitochondria, but in
mammalian systems, the human hFis1 is not essential for Drp1recruitment [62,63]. However Fis1 is required for Dnm1 to assemble
into the functional oligomers that drive the scission event [61,64,65].
The molecular link between hFis1 and Drp1 likely requires an adaptor
protein with functional similarity to the yeast Mdv1 (Mitochondrial
division 1) and Caf4 (Caffeine-resistant 4) [65–68]. Mdv1 is required
for mitochondrial ﬁssion in yeast, and Caf4 is a very similar protein
that appears to have an overlapping function. Both are soluble,
cytosolic proteins that contain WD40 repeat domains and are known
to form a complex with Dnm1 and Fis1. The human orthologue of
these proteins remains elusive.
Other factors modulating mitochondrial division have also been
reported. GDAP1 (ganglioside-induced differentiation associated pro-
tein 1) is a mammalian mitochondrial outer membrane protein that
regulates the mitochondrial network by promoting mitochondrial
ﬁssion [69,70]. GDAP1 contains a characteristic Glutathione-S-Trans-
ferase domain (GST) and a C-terminal hydrophobic signal-anchor
sequence required for its activity. Given that GDAP1 contains a GST
motif, it has been speculated that GDAP1 could provide a mechanism
to regulate mitochondrial fusion based on the redox state of the
mitochondria [70]. Interestingly, GDAP1 mutations have been asso-
ciated with pathogenesis of Charcot-Marie-Tooth type 4A disease [71–
73], supporting an essential role of GDAP1 in the control of
mitochondrial dynamics and human physiology.
Just as mitochondrial fusion depends upon a mitochondrial-
anchored phospholipase D to modulate the lipid composition at the
site of fusion, mitochondrial ﬁssion also requires at least one protein
known to alter membrane properties. Endophilin B1 (Bif1/SH3GLB1),
a protein related to endophilin1, is recruited to the mitochondria
where it is required for mitochondrial ﬁssion [74]. Endophilin B1
cycles between the cytosol and the membrane where it binds through
its Bin-Amphiphysin-Rvs (BAR) domain. This domain is thought to
either sense, or generate membrane curvature that would help
facilitate the membrane pinching that is required during ﬁssion
[75]. Interestingly, the subcellular distribution of Endophilin B1 is
governed by both autophagy [76] and apoptotic signals [77]. It has
been shown to bind to Beclin1 and during nutrient depletion, it
colocalizes with the autophagy related proteins, Atg9, LC3 and Atg5
within punctate foci [76]. This complex appears to assemble on small
vesicles that fuse together to form the pre-autophagosome. Whether
or not this function in autophagy requires mitochondrial membranes
remains unclear. However, Drp1was recently shown to be required for
mitochondrial turnover through autophagy [78], hinting that Endo-
philin B1 may be important in regulating mitochondrial ﬁssion and
Drp1 function during autophagy.
It seems likely that mitochondrial ﬁssion plays a speciﬁc and
critical role during autophagy. Shirihai and co-workers reported that
Drp1-dependent mitochondrial ﬁssion can result in an asymmetry
within the two dividing mitochondria, where one of the two
mitochondria has conserved a high electrochemical potential, and
the other has a reduced membrane potential and low levels of the
fusion GTPase OPA1. This loss of OPA1 could render some of these
fragments with low ΔΨ to become fusion incompetent, leading to
their ultimate removal by the autophagosome [78]. It was similarly
reported that mitochondrial ﬁssion induced by nitric oxide could be
asymmetric [79], where one daughter mitochondria retained normal
ultrastructure while the other one displayed disorganized cristae
structure. The segregation of mitochondrial fragments that are fusion
incompetent and instead somehow targeted for speciﬁc autophagic
turnover is an emerging area of study.
2.2.2. Inner membrane ﬁssion machinery
Several observations support the model that both mitochondrial
membranes utilize independent machinery that functionally sepa-
rates the ﬁssion of the mitochondrial inner membrane and the outer
membrane. However, we have not yet identiﬁed any absolute
candidate proteins that play a core function to drive mitochondrial
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inner membrane protein Mdm33 [44], which is anchored within the
inner membrane with its N-termini exposed to the matrix and its C-
termini domain containing coiled-coil motifs facing the intermem-
brane space. Biochemical analysis revealed that Mdm33 also forms
higher order oligomers [80]. The loss of Mdm33 function led to highly
fused mitochondria, with the resulting organelles displaying altera-
tions within the internal cristae structure of mitochondria with
elongated stretches of outer and inner membranes enclosing a very
narrow matrix space [80]. From these data, Mdm33 has been
proposed to play a speciﬁc role in ﬁssion of the mitochondrial inner
membrane. The function of Mdm33 and potential interacting partners
implicated in the maintenance of the inner membrane architecture
and dynamics are still uncharacterized. To date, no homologue of
Mdm33 has been reported in higher eukaryotes. However, in
mammals, an intermembrane space protein anchored to the inner
membrane, MTP18 (mitochondrial protein, 18 kDa), was shown to be
required for mitochondrial ﬁssion [81,82]. Considering its localization,
it is tempting to speculate that MTP18 could control the concerted
ﬁssion of outer and inner membranes. The regulation of this
component is remarkable since it has been ﬁrst described as a
transcriptional downstream target of phosphatidylinositol (PI) 3-
kinase signaling and is essential for cell viability [81]. This protein
could represent a new target for the modulation of mitochondrial
dynamics in response to physiological changes in the cellular
environment.
Finally, Dap3 (death associated protein 3) is a mitochondrial
matrix protein containing a GTP-binding motif and was identiﬁed as
another regulator of mitochondrial fragmentation [83]. Dap3 is a
mitochondrial ribosomal protein that plays a role in mitochondrial
protein synthesis in healthy cells [84]. Transient overexpression of
Dap3 induced fragmentation of the mitochondria and this effect was
dependent on its GTP-binding activity. However, Dap3 RNAi treated
cells show a normal mitochondrial phenotype [83], indicating its role
as a regulatory factor rather than a core component of any ﬁssion
complexes. As with othermembers of the ﬁssionmachinery, Dap3was
also shown to have a conserved role in apoptosis pathways [84,85].
Silencing of Dap3 did display a signiﬁcant reduction of mitochondrial
fragmentation induced by apoptosis [83], suggesting that Dap3 is
likely activated during cell death to promote mitochondrial fragmen-
tation. It has been proposed that the activation of Dap3 may involve
the phosphorylation of residues around the GTP-binding motif [86],
however future work is required to determine the potential kinases/
phosphatases that regulate the function of Dap3 and its role in the
regulation of mitochondrial fragmentation and cell death.
2.2.3. Regulation of mitochondrial ﬁssion
Recent discoveries have demonstrated that mitochondrial division
is also regulated by ubiquitination, SUMOylation and phosphorylation
[87–91]. MARCHV/MITOL is a mitochondrial ubiquitin ligase that
spans the outer membrane of mitochondria four times, with the
conserved RING-ﬁnger domain exposed to the cytosol [87,92,93]. This
ligase associates with both hFis1 and Drp1 and mediates the
ubiquitination of these ﬁssion components to promote mitochondrial
ﬁssion. In addition to these interactions with the ﬁssion machinery,
MARCHV was also shown to bind Mfn2, but not Mfn1 [87]. Although
biochemical experiments have shown these interactionswith both the
fusion and ﬁssion machinery, the silencing of MARCHV led to an
inhibition of mitochondrial ﬁssion, resulting in highly elongated
mitochondria. This suggests a functional requirement for MARCHV in
the activity of Drp1 and hFis1, rather than Mfn2. Experiments
overexpressing MARCHV or mutants of the protein did not lead to
changes in the protein levels of its potential targets, suggesting that
the ubiquitination activity of MARCHV does not lead to changes in
protein turnover, instead playing a signiﬁcant role in the regulation of
ﬁssion complex assembly or disassembly.Drp1 cycling between the cytosol and the membrane is also
dependent on SUMOylation, [63,88,89]. SUMO (Small ubiquitin-like
modiﬁer) is a small protein that, like ubiquitin, becomes covalently
conjugated to target substrate proteins through a series of enzymatic
reactions involving a heterodimeric E1 enzyme, an E2 SUMO ligase
called UBC9, and a SUMO E3 ligase, which provides substrate
speciﬁcity. The consequence of SUMOylation upon its target varies,
but generally leads to a change in protein conformation resulting in
altered complex assembly, localization or function (for review see
[94]). Initially discovered through a yeast two-hybrid interaction
screen, the SUMOylation of Drp1 is a transient, sub-stoicheometric
modiﬁcation [88]. Overexpression of SUMO1 [88], or silencing of the
speciﬁc SUMO/Sentrin protease 5 (SenP5) [89], both lead to an
increase in the stability of Drp1 from degradation, and increase the
membrane association of Drp1 and mitochondrial fragmentation.
Importantly, there are a number of unidentiﬁed mitochondrial
proteins that are a target of SUMOylation [88,89] indicating that the
identiﬁcation of the enzymes that regulate these modiﬁcations will
lend important insights into the physiological importance of these
processes.
Finally, Drp1 is also phosphorylated by cyclin B1, cAMP and
calcium signals [90,91,95]. The functional consequence of Drp1
phosphorylation depends upon which residue is modiﬁed. The
regulation of mitochondrial ﬁssion through post-translational mod-
iﬁcations is providing new insights into how this process can be
responsive to intracellular signals. These links are highlighted in the
later sections of this review.
2.3. Cristae architecture
The mitochondrial inner membrane is highly folded to form
cristae emerging from the membrane through tubular connections
called crista junctions [96]. This internal structure is highly plastic
and is altered depending on the metabolic state of the organelle
[97]. Cristae morphology has been shown to vary between two
extreme morphologies, namely the condensed and the orthodox
state [98,99]. The orthodox state shows narrow cristae presenting
few junctions with the inner membrane space together with an
expanded matrix. Conversely, the condensed state is characterized
by large cristae with multiple cristae junctions and a condensed
matrix. It appears that the conversion between these two states
requires the fusion and ﬁssion of the inner membrane, suggesting
that these internal morphological changes are partially dependent
on the machineries governing membrane remodeling of the
organelle. This is in agreement with the role of OPA1 in maintaining
cristae structure [100,101]. In OPA1 RNAi treated cells, the
mitochondria display disorganized cristae and enlarged cristae
junctions, while in cells overexpressing OPA1, narrow cristae and
cristae junctions are observed {Olichon, 2003 #84; Frezza, 2006
#679}. The role of OPA1 in regulating the mitochondrial cristae
structure remains to be clariﬁed. Nevertheless, it appears that the
function of OPA1 in cristae structure can be dissociated from its
function in mitochondrial fusion [101]. Another important element
controlling the cristae structure is the oligomerization of ATP
synthase [102,103]. In yeast, oligomerization of ATP synthase is
dependent on the dimerization of the complex and is required to
generate mitochondrial cristae [102]. Dimerization of ATP synthase
is mediated by the interface composed of subunits e and g [104–
106]. Recently, phosphorylation of a serine residue of subunit g has
been shown to regulate the dimerization of the complex, describing
a new mechanism in the regulation of mitochondrial inner
membrane dynamics [107]. The kinase, phosphatase and general
signaling cascades responsible for regulating subunit g phosphoryla-
tion are unknown. Moreover, a link between Mgm1 and the ATP
synthase has been proposed where Mgm1 could act as an upstream
regulator of the subunit e stability [108].
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cristae are known to accompany programmed cell death. It has been
observed that the cristae junctions are disassembled during cell death,
leading to an increased accessibility of proteins like cytochrome c to
the outer membrane permeability transition pore [109–111]. The
reorganization of the cristae structures during cell death also involves
OPA1, but Drp1 appears to lie upstream of cristae remodeling during
cell death [110]. This is likely due to the recruitment of factors like
Endophilin B1 that may change the ﬂuidity or curvature of the outer
mitochondrial membrane [74,77]. One could imagine these changes
affecting the stability of the contact sites and cristae junctions, leading
to inner membrane remodeling. However, the current list of proteins
that modulate inner membrane dynamics is insufﬁcient to provide
any detailed mechanistic insights into the true nature of the dynamic
changes in the cristae. Understanding the link between cristae
plasticity and the metabolic or apoptotic status of the mitochondria
will be essential to explain the functional relevance of the mitochon-
drial membrane architecture.
2.4. Motility and mitochondrial positioning
Whether mitochondria aremigrating into the yeast bud during cell
division, or are transported to the axon in primary human neurons,
mitochondrial motility is an essential aspect of mitochondrial
dynamics. The ability to position the mitochondria within the cell is
crucial for the development of many polarized cells both during, and
after cellular differentiation [7,112]. The primary function for mito-
chondrial positioning is likely to provide local ATP and buffer calcium
transients [113,114]. However, somemore recent studies are beginning
to indicate that the mitochondria may also function as a unique and
essential signaling platform (Fig. 2). In this capacity, the positioning of
the mitochondria within polarized cells may be important for
signaling cascades in addition to its role in maintaining energy
capacity [113,115]. Mitochondrial motility in neurons has been an
intensively studied area of research and represents a model for
directed mitochondrial movement. In mammalian cells, mitochondria
are transported alongmicrotubules in an anterogrademovement fromFig. 2.Mitochondria as critical signaling platforms. Themitochondria are important cellular p
and metabolic responses. In (1), external signals, like signals for growth, or viral infection a
MAVS and FKBP38. The engagement of these mitochondrial proteins leads to the activatio
growth programs. In (2), signals can be initiated fromwithin the mitochondria, including the
cellular programs, including cell cycle progression from G1 to S and apoptosis. The identiﬁcat
that additional mechanisms may play a prominent role in transducing mitochondrial signalthe cell body to the distal portion and in retrograde movement in the
opposite direction. Interestingly, mitochondria with high membrane
potential preferentially migrate in the anterograde direction and
conversely, mitochondria with low membrane potential progress in
the retrograde direction [116]. Thus, mitochondrial motility and
energy state seem to be coupled although the mechanisms controlling
this selection are unknown.
Mitochondrial distribution in neurons involves the molecular
motors kinesin-1 (KIF1B) and kinesin-3 (KIF5B), along with the
cytoplasmic dynein [117]. The nature of the interactions between
mitochondria and these factors is unclear and can involve lipid
binding or the presence of adaptors. In Drosophila, the two proteins
Milton andMiro have been identiﬁed as adaptor complex that anchors
kinesin-1 to mitochondria [118,119]. Miro is a Rho-like mitochondrial
outer membrane GTPase containing calcium-binding motifs. In yeast,
Gem1, the Miro orthologue, also contains Rho GTPase and EF-hand
domains essential for mitochondrial distribution and morphology
[120]. The presence of these conserved domains within Miro strongly
suggests that the movement of mitochondria is regulated by both
GTPase switchmechanisms and calcium signaling pathways. Miro also
functions as an adaptor for Milton, which binds directly to the kinesin
heavy chain [121]. The binding of Milton to the heavy chain competes
for the light chain, and leads to the formation of a Miro/Milton/Kinesin
complex. The reasonwhy Milton appears to have replaced the kinesin
light chain is unclear, but it has been proposed that Milton may not be
the only protein that functionally replaces the kinesin light chain in
the regulation of microtubule based movement [121]. This complex is
essential for the transport of mitochondria within the Drosophila
oocyte [122], and axonal transport of mitochondria in neurons [119].
Milton does not appear to be conserved in yeast, perhaps reﬂecting the
primary dependence of yeast mitochondria on the actin cytoskeleton
rather than microtubules. Syntabulin is another adaptor molecule
initially identiﬁed as a syntaxin-binding protein linking syntaxin-
containing vesicles to kinesin heavy chain [123]. Syntabulin is also a
linker between mitochondria and motor protein KIF5B and partici-
pates in the anterograde trafﬁcking [124,125]. Syntabulin directly
binds the kinesin heavy chain and its carboxyl-terminal tail islatforms that both propagate and initiate intracellular signals that lead to overall cellular
re sensed by novel proteins anchored in the mitochondrial outer membrane, including
n of downstream signaling complexes that ultimately affect cellular transcription and
intuitive changes in the production of ROS or ATP levels. These metabolites affect many
ion of many newmitochondrial kinases, phosphatases and GTPases like PINK1 suggests
s within the cell. See text for details.
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identiﬁed cellular requirements for mitochondrial movement, includ-
ing cyclin-dependent kinase 5 (CDK5), protein phosphatase 1 (PP1)
and glycogen synthase kinase 3 beta (GSK3beta) [126–128]. However,
the mechanisms and regulation of these pathways are also unclear.
Hollenbeck and colleagues demonstrated that the movement of
mitochondria along the axon can be regulated by the local addition of
nerve growth factor, NGF [112,129]. Using NGF-coated beads, they
showed that the activation of the TrkA receptor led to an accumulation
of mitochondria in the vicinity of the bead. This relocalization
depended upon PI(3)kinase activity, and was due to a shift of
mitochondria from a microtubule association to their more stable
association with actin ﬁlaments [129]. The speciﬁc role of Miro or
Milton has not yet been examined within this experimental model. A
more recent study has identiﬁed WAVE1, or Wiskott–Aldrich
syndrome protein (WASP)-family verprolin homologous protein 1, as
an important factor that triggers the movement of mitochondria into
dendritic spines in response to NMDA (N-methyl-D-aspartic acid)
receptor activation [130]. NMDA receptor activation triggers the
formation of new ﬁlopodia and dendritic spines, leading to long
term potentiation. The examination of actin based changes respon-
sible for ﬁlopodia formation led to a careful examination of WAVE1,
since it is known to activate the actin-related protein, Arp2/3 complex,
leading to the robust formation of actin ﬁlaments. WAVE1 has been
previously localized to the mitochondria, however its function there
had been unclear [131]. Using isolated primary cortical neurons, it has
now been shown that the activation of NMDA receptors leads to
transient neuronal depolarization, and the downregulation of the
regulatory p35 subunit of Cdk5. Cdk5 is the kinase that maintains
WAVE1 in a phosphorylated, inactive state. Upon the downregulation
of p35, WAVE1 becomes activated and facilitates the recruitment of
mitochondria into the dendritic spines. It had previously been shown
that only small fragments of mitochondria can become enriched at the
base, or within, these spines, suggesting that there may also be some
link between WAVE1 activation and the shift to more fragmented
mitochondria during neuronal depolarization. The switch to an actin
based motility from long-range microtubule based movement of
mitochondria along the axonal shaft may also be explained by the
recruitment of the Arp2/3 complex to the mitochondrial surface.
It has long been observed that mitochondria are highly enriched
within the synapse, yet it has been unclear how this asymmetric
distribution is maintained. A recent study has shed new light on this
question through the identiﬁcation of Syntaphilin as a docking
receptor for mitochondria targeted to the axon [132]. Syntaphilin is
a direct docking receptor that it is associated with the outer
membrane of mitochondria by its hydrophobic carboxyl-terminal
tail and interacts with the cytoskeleton through its microtubule-
binding domain. This protein represents a new target for the
regulation of mitochondrial stationary phase in neurons. Interestingly,
phosphorylation of syntaphilin by cAMP-dependent protein kinase A
(PKA) decreases its interaction with syntaxin-1 [133] and it can be
hypothesized that cAMP-dependent transduction pathway may
similarly affect the role of syntaphilin in mitochondrial docking.
Further investigations will determine whether cellular signals and
synaptic activity can modulate its function.
In addition to neuronal synapses, mitochondrial positioning has
recently been shown to play a critical role in the formation of
immunological synapses as well [134]. In this study, the mitochondria
within the T-helper cells were shown to move rapidly towards the
immunological synapse formedwith the antigen presenting cell. Once
there, themitochondria sit within 200 nm from the plasmamembrane
where their presence was required to maintain the calcium-
dependent T-cell activation. The mitochondria recruited to the
synapse showed signiﬁcantly higher calcium transients relative to
those located further away, suggesting a speciﬁc role in modulating
local calcium-dependent signaling complexes. Within migrating T-lymphocytes, it was also shown that the movement of fragmented
mitochondria into the uropod was required for the propagation of the
cell [135]. If the mitochondrial reticulum was highly fused, lympho-
cyte migration was signiﬁcantly reduced, providing evidence that the
machinery governing mitochondrial position and morphology must
be integrated into the signals that drive cellular polarization and
migration. Indeed, the movement of mitochondria depended on G-
protein signaling and microtubule dynamics, as relocalization was
inhibited by pertussis toxin and nocodazole [135]. Based on additional
experiments manipulating the ATP levels in the cell, the authors
concluded that the requirement for mitochondrial localization within
the uropod helped to ensure a high capacity of ATP to drive themyosin
motors responsible for the cellular migration.
Finally, components of the protein import machinery have also
been shown to have a dual function in import and in the regulation of
mitochondrial motility and position. In yeast, mitochondrial morphol-
ogy proteins Mmm1, Mdm10 and Mdm12 have a major role in the
assembly of β-barrel proteins in the outer mitochondrial membrane
[136–138], where Mdm10 plays a speciﬁc role in the ﬁnal stages of
assembly of the TOM complex [136]. In addition to these established
roles, Mmm1 andMdm10may control the interaction of the organelle
with actin, pointing to a possible regulation of mitochondria motility
[139]. Finally, the outer membrane Mmm1, Mdm10, Mmm2 and
Mdm12 [139,140] and the inner membrane proteins Mdm31 and
Mdm32 [141] have been shown to colocalize with nucleoids, and they
may play a direct role in their assembly and/or function. In summary,
the regulation of mitochondrial movement is highly coordinated
through multiple signaling pathways that require the participation of
a large number of proteins. Many of these appear to have dual
functions and future work will continue to uncover the relationships
between these players.
2.5. Mitochondrial derived vesicles
Recently, a new aspect of mitochondrial dynamics has been
revealed with the identiﬁcation of carrier vesicles emerging from
mitochondria [142]. These mitochondrial derived vesicles (MDVs) are
uniform in size, between 70–100 nm, and contain selected mitochon-
drial cargo. Moreover, they are formed by a lateral segregation and
enrichment of the cargo and the budding process does not require the
dynamin Drp1, suggesting the existence of a machinery independent
of the ﬁssion apparatus. These proﬁles contained either one or both
mitochondrial membranes present as concentric rings, with cristae
rarely observed. Their discovery came with the identiﬁcation and
characterization of a new outer membrane mitochondria-anchored
protein ligase calledMAPL. Overexpression of MAPL leads to the Drp1-
dependent mitochondrial fragmentation, suggesting that this mito-
chondrial RING-ﬁnger containing protein may play a role in the
regulation of mitochondrial ﬁssion. Whether the activation of Drp1 is
through potential ubiquitin or SUMO E3 ligase activity within the
RING-ﬁnger remains to be clariﬁed [143]. Regardless of its role in
stimulating mitochondrial ﬁssion, the surprise came when examining
cells where this fragmented phenotype was rescued by the inhibition
of Drp1. In these cells, the mitochondria were highly interconnected,
as is the expected phenotype upon inactivation of Drp1. However,
although ﬁssion was inhibited, EM and confocal imaging demon-
strated that MAPL was still found in vesicular mitochondrial
structures, termed mitochondrial derived vesicles (MDVs). Remark-
ably, MAPL-containing vesicles selectively excluded mitochondrial
protein Tom20 and vice-versa demonstrating that MDVs contain
selected cargo. Furthermore, MAPL-containing vesicles were shown to
fuse with a subset of peroxisomes [142]. Since the distinct vesicle
population labeled with Tom20 does not fuse with peroxisomes, it
appears that the cargo speciﬁcity is a primary determinant of MDV
fate [142]. Further investigations are required to uncover the function
and fates of the vesicle populations that are not addressed to the
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mitochondrial cargo to the peroxisomes offers the ﬁrst molecular
mechanism for the trafﬁc between these two organelles. The exact
nature of these MAPL-containing vesicles and their role in peroxi-
somes physiology remain to be determined. Nevertheless, the
description of machineries controlling the recruitment of the cargo
and the budding process promises to be a very exciting ﬁeld.
The process of MDV formation may provide explanations for two
unique aspects of mitochondrial phenomenology; ﬁrst that some
mitochondrial proteins or complexes are found at extra-mitochondrial
sites [144,145], and second, that asymmetric mitochondrial ﬁssion is
becoming much more commonly observed [78,79]. The unexpected
ectopic localization of mitochondrial proteins is best exempliﬁed by
the presence of mitochondrial ATP synthase complex at the cell
surface of endothelial cells where it plays an essential role in lipid
metabolism [145–147]. Although some proteins are dually targeted to
different organelles, the ATP synthase complex contains 2 proteins
encoded by the mitochondrial genome. Therefore, it is obligate that
this complex assembles within the inner membrane prior to its
appearance on the cell surface. Currently, there is no described
mechanism able to explain the transport of this complex necessarily
assembled in the mitochondria to another cell compartment. It is
reasonable to hypothesize that the MDVs could fulﬁll the role of
carrier vesicles to transport mitochondrial proteins to other destina-
tion. Second, the establishment that MDVs incorporate only selected
mitochondrial cargo provides further support for the previous
evidence that the mitochondria, like other organelles, have the
capacity to laterally enrich selected proteins for various purposes. At
least two reports suggest that the ﬁssion of fusion-incompetent
mitochondria allow for selective degradation of damaged fragments
[33,78]. This concept presupposes that damaged mitochondrial cargo
and lipid must reside preferentially within the fusion incompetent
half of the segregated fragment. Interestingly, there has also been a
series of new studies indicating that mutated mtDNA is somehow
selected against during early embryogenesis [148,149]. Although the
mechanisms that underlie this process remain obscure, it is likely that
there is some form of selective autophagy of mitochondrial fragments
containing the mutant mtDNA. Therefore, the discovery that the
mitochondria are able to bud vesicles containing selected cargo is
perhaps not wholly unexpected and may provide a new framework to
study the mechanisms that govern selective mitochondrial trafﬁc. The
challenge is to understand the regulation of Drp1-independent vesicle
formation and how this process may functionally differ from Drp1-
dependent asymmetric mitochondrial ﬁssion.
3. Integration of mitochondrial dynamics within intracellular
signaling cascades
The machineries described above provide the mechanisms to
control the positioning of the mitochondria within the cell, the
ultrastructure of the cristae membranes and the interconnectivity of
the mitochondrial reticulum. Together these elements ensure that the
metabolic engine is well positioned for the cell to function properly.
Recent work by a number of laboratories has shed light on the
mechanisms by which the cellular signals can inﬂuence the
mitochondrial morphology machinery under distinct cellular condi-
tions, from apoptosis to cell division (Fig.1). The ﬂow of information
from the cell to the mitochondria allows the exquisite regulation of
mitochondrial function. The importance of this ﬂow is becomingmore
evident as a number of disease conditions like Parkinson's, Charcot-
Marie Tooth Type 2A, andmany others appear to progress because of a
direct effect on mitochondrial dynamics [1]. Therefore the regulation
of mitochondrial morphology in cellular physiology has a profound
impact on human health and development.
In addition to signaling from the cell to the mitochondria, the
mitochondria also have a strong capacity to initiate signaling cascadesthat can directly inﬂuence cellular behavior. Pioneering work on
retrograde signaling was done by Ron Butow, to whom this review is
dedicated, who focused on the stimulation of mitochondrial biogen-
esis due to accumulating mitochondrial dysfunction [150–152]. As
predicted by thework of Butow, exciting new studies are continuing to
expand these ideas. Critical signaling pathways including those
involved in immunity and cellular proliferation are transduced in a
manner dependent upon the activities of novel mitochondrial-
anchored signaling complexes. The requirement for the mitochondria
within these pathways is unexpected and it is not yet clear what the
functional implications might be. However, with the molecular
identity of mitochondrial signaling complexes, we now have a starting
point to explore the signiﬁcance of these ﬁndings. One might predict
that the activity of these new complexes in transducing retrograde
mitochondrial signaling will depend upon the precise positioning of
the mitochondria, the co-ordination of membrane microdomains, and
the regulation of metabolic outputs. Therefore, the machinery that
regulates mitochondrial morphology must be incorporated within
mitochondrial signaling pathways. These concepts will be expanded
upon in the sections below.
3.1. Anterograde signaling
3.1.1. Metabolism and morphology
One of the ﬁrst correlates that emerged from the examination of
mitochondrial dynamics was that the loss of mitochondrial fusion led
tomitochondrial depolarization, loss of mtDNA, and a general inability
to respire [7,153–156]. These data suggested that the process of
ongoingmitochondrial fusionwas essential tomaintainmitochondrial
function. The loss of the mitofusins or OPA1 in cultured cells led to a
nearly complete loss in respiration [156], and the loss of these proteins
in animal models led to early embryonic lethality [7,157]. In general,
the ability to share metabolites within the mitochondrial reticulum
has been considered an important factor for metabolic stability.
Metabolites within the mitochondria may become concentrated
within the intercristal membranes, allowing their efﬁcient use by
the respiratory chain [97,103,158]. However, should the regulation of
cristae assembly be compromised, then these stores may become
depleted. Therefore it has been proposed that the shape-shifting
machinery ensures that the cristae remain both properly assembled
and dynamic, thereby allowing a regulated distribution of metabolites
within an organelle, and the reticulum. This may appear intuitive in
some ways, however it is still not clear why the shape of the
mitochondria should so profoundly affect the enzymatic activity of the
respiratory chain. Nevertheless, since the plasticity of the mitochon-
dria is essential for metabolism, then the machinery that modulates
mitochondrial dynamics represent an excellent axis for metabolic
regulation.
There is some evidence that the fusion/ﬁssion machineries are
modulated in response to changes in the metabolic conditions of the
cell. For example, in conditions of high glucose, where the mitochon-
dria must catabolise pyruvate very quickly, the mitochondria were
seen to undergo a Drp1-dependent fragmentation event that occurred
in the ﬁrst 10–15 min of glucose addition [159]. This morphological
change was reversible, and within 30–60 min, mitochondria had
returned to their previous, tubular state. Surprisingly, inactivation of
Drp1 dramatically inhibited pyruvate uptake into the mitochondria,
the respiration increase and associated ROS production, emphasizing
the control of mitochondrial metabolism by themorphological state of
the organelle. It remains unclear how Drp1 activity is regulated in
response to the inﬂux of glucose, but given the multiple post-
translational modiﬁcations encountered by Drp1, it is likely to be a
direct target of the signaling activities linked to glucose uptake. In
general, it appears that mitochondrial ﬁssion may be required to
induce inner membrane remodeling in order to adapt mitochondrial
metabolism for optimal metabolic output. This observation highlights
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alone cannot be interpreted as a sign of respiratory incompetence.
Instead, mitochondrial plasticity — or the ability of the mitochondria
to fuse and divide in a coordinated manner, appears to be the critical
element determining mitochondrial function.
Given that Mfn2 overexpression or silencing affects metabolism it
has been considered that mitochondrial fusion may directly or
indirectly play a role in relaying cellular cues to metabolic outputs
[156,160,161]. It has not yet been determined whether or how the
fusion machinery becomes activated in response to cellular signaling.
One potential clue may be that mutations within the intermembrane
space domain of Mfn2 completely inhibit mitochondrial fusion, even
though the GTPase and cytosolic heptad repeat domains are intact
[10]. These intermembrane space residues are not themselves
required for the fusion reaction, since an Mfn2 construct harboring
both the IMS mutation, and the dominant active mutation within the
GTPase domain, fused in a highly stimulated manner. These data
suggest that the intermembrane space region of Mfn2 may be
required to activate the protein and drive mitochondrial fusion,
suggesting that the impetus for mitochondria to fuse may be derived
from their individual metabolic status. This does not exclude the
additional possibility that cytosolic factors may also activate the
mitofusins through their GTPase domains and trigger organelle fusion
based on metabolic cues. The potential upstream factors that regulate
Mfn2 activation and Drp1 recruitment to the mitochondria will be
important to identify in the future.
3.1.2. Apoptosis
The requirement for the ﬁssion machinery, including Drp1,
endophilin B1 and hFis1 in the efﬁcient progression of cell death
has been demonstrated in most cellular model systems studied, from
cultured cells to primary neurons [77,162–164]. In addition, Drp1 has
been implicated in the progression of apoptosis in a number of genetic
and developmental models, including C. elegans, Drosophila and yeast
[165–169]. In all three cases, the loss of Drp1 (or Dnm1) led to an
increase in interconnected mitochondria and inhibition of devel-
opmentally regulated, or age-related, cell death. In contrast, a
conditional knock-out mouse where Mfn2 loss was initiated within
the cerebellum following birth, revealed a nearly complete loss of
Purkinje cells, strongly indicating that the fusion machinery plays a
critical role in the protection of cells against mitochondrial dysfunc-
tion and cell death [11]. Similarly, the loss of Mfn2 using lentiviral
delivered siRNA within cultured primary cortical neurons led to the
induction of cell death, whereas infection of the dominant active form
of Mfn2 provided signiﬁcant protection against a number of apoptotic
stimuli [170]. These and many other studies have provided a solid
foundation for the examination of mitochondrial dynamics during
apoptosis.
The genetic links between cell death and mitochondrial morphol-
ogy are important, but the molecular details of these processes are
also rapidly emerging. It has been observed for some time that the
mitochondria undergo dramatic changes in their morphology upon
apoptotic stimuli, including an increase in fragmentation [162],
inhibition of mitochondrial fusion [171], opening and remodeling of
the cristae [109,110] and release of apoptotic proteins like cytochrome
c, apoptosis-inducing factor (AIF), HTrA2/Omi (High temperature re-
quirement A2), Endonuclease G, OPA1 and Smac/Diablo [172].
Although there is still some debate whether mitochondrial fragmen-
tation is essential for cell death [173,174], it is generally accepted that
the mitochondrial fragmentation that accompanies apoptosis is an
early, Drp1-dependent event that requires the presence of active Bax/
Bak. The precise nature of the molecular intersection between Drp1
and the pro-apoptotic proteins is unclear, however they are known to
coalesce into distinct foci on the mitochondrial membrane [63,175],
indicating a local assembly of macromolecular networks. These Bax/
Bak-dependent apoptotic complexes are extremely stable as deter-mined by the lack of recovery of Drp1-YFP (yellow fluorescent pro-
tein) within these foci after photobleaching [63]. Interestingly, the
formation of such stable complexes of Drp1-YFP on the mitochondrial
surface coincides with the stable, Bax/Bak-dependent SUMOylation of
Drp1, implicating this modiﬁcation as a part of the mechanism for the
modulation of Drp1 function during apoptosis.
In addition to SUMOylation, the phosphorylation of Drp1 also plays
a role in apoptosis. It was recently demonstrated that the regulation of
Drp1 GTPase activity is dependent on phosphorylation within the
GTPase effector domain (GED) by protein kinase A (PKA) [91,95].
Phosphorylation of Ser-637 within human Drp1 by the cAMP-
dependent protein kinase causes a signiﬁcant reduction of the GTPase
activity, and since hydrolysis of GTP is requisite to drive mitochondrial
ﬁssion, the phosphorylation led to an inhibition of mitochondrial
division [91]. Mechanistically, the use of a phosphomimetic mutant
provided evidence that the interaction between the GED and the GTP-
binding domain was disturbed upon phosphorylation, providing an
explanation for the inhibition of GTP hydrolysis within Drp1. Although
this precise mechanism was challenged by another study reporting
that the same phosphomimetic mutant did not affect GTPase activity
[95], the ﬁssion activity of Drp1 was also reduced upon phosphoryla-
tion. Moreover, the dephosphorylation of this site is mediated by
calcineurin also known as protein phosphatase 2B (PP2B), possibly
providing a molecular explanation for the role of calcium signaling in
the activation of Drp1-dependent mitochondrial ﬁssion [95,110,176].
These studies further proposed that this regulatory network of
phosphorylation can play an important role in the control of apoptosis.
Indeed, the pseudo-phosphorylation of the Ser residue led to a fused
mitochondrial reticulum that was resistant to cell death, whereas the
Serine to Alanine mutation led to an increased sensitivity to apoptosis
[95]. It is important to note that cAMP and calcium regulate multiple
physiological programs, therefore this regulatory network is likely to
have a more fundamental role in the adaptation of mitochondria to
changes in cellular ATP requirements. For example, during short-term
adaptation of mitochondria to the cellular energy demand, Ca2+
signaling induces the activation of mitochondrial ATP production
[177,178]. As described earlier, the transient activation of Drp1 can
facilitate pyruvate uptake and increased respiration [159], perhaps
indicating that the dephosphorylation of Drp1 by calcineurin upon
calcium based signaling may lead to its increased recruitment and
ﬁssion activity.
Although Drp1 initially received themost attention as an apoptotic
regulator, recent studies have provided more direct molecular links
between the pro-apoptotic proteins and Mfn2. It was ﬁrst shown that
the activation or overexpression of the mitofusin proteins is protective
against apoptosis, suggesting that ongoing fusion, or the fusion
machinery itself, could interfere with the progression of cell death
[142,179]. Later, the use of a photoactivatable GFP basedmitochondrial
fusion assay revealed that fusionwas indeed inhibited during the early
stages of apoptosis, which was an event distinct from the activation of
mitochondrial ﬁssion and the involvement of Drp1 [171]. Richard
Youle and colleagues further showed that the pro-apoptotic machin-
ery of Bax and Bak were required for the normally high levels of
mitochondrial fusion in steady state, non-apoptotic conditions [180].
More speciﬁcally, Bax and Bak play a role in the control of
mitochondrial fusion by modulating the distribution and motility of
Mfn2 into foci and promoting its assembly into large complexes. The
Bax/Bak-mediated modulation of Mfn2 localizationwas also shown to
depend on the nucleotide state of the Mfn2, with the GTP-bound form
losing responsiveness to the pro-apoptotic proteins. This is consistent
with the observation that the GTP-bound form of Mfn2 provides
signiﬁcant protection against Bax-mediated cell death.
The studies described above made use of the Bax/Bak double
knock-out cell lines, however it was recently demonstrated that much
of the regulation of mitochondrial morphology may be through the
actions of Bak rather than Bax [181]. The introduction of Bak alone into
163V. Soubannier, H.M. McBride / Biochimica et Biophysica Acta 1793 (2009) 154–170the DKO cell lines rescued mitochondrial fusion, and Bak was shown
to bind both Mfn1 and Mfn2. Interestingly, upon cell death, Bak
releases Mfn2 and preferentially binds to Mfn1. Mutations in the BH3
domain of Bak which are essential for the stimulation of cell death did
not affect the interaction with Mfn1, and still bound to Mfn2 under
non-apoptotic conditions. However, upon apoptotic treatment,
mutated Bak did not release Mfn2, suggesting that the release of
Mfn2 from this complex is requisite for the progression of cell death
[181]. Finally, it was also reported that the anti-apoptotic Bcl-XL, but
not Bcl-2, binds speciﬁcally to Mfn2, and expression of Bcl-XL led to an
increased mitochondrial fusion [182]. More work is needed to dissect
the mechanisms that deﬁne these complexes and their apoptotic
transitions, but it is evident that both the pro- and anti-apoptotic
machinery plays a direct role in the regulation of the fusion GTPases.
Given the emerging links between the pro-apoptotic machinery and
their role as sentinels of the cellular metabolic state [183,184], these
links may eventually provide new insights into the metabolic
regulation of mitochondrial fusion.
3.1.3. Cell cycle
One of the more curious aspects of mitochondrial biology is
whether, and if yes, how mitochondrial biogenesis and mtDNA
replication may be coupled to the stages of cell cycle progression.
Early evidence indicated that mtDNA did not increase during the S
phase of the cell cycle, indicating that the replication of the two
genomes is not temporally linked [185,186]. Instead, mitochondrial
mass appeared to increase most during the growth phase of the cell
cycle, as might be anticipated due to increased energy demands.
Therefore the most obvious link between regulated mitochondrial
behavior/morphology and the cell cycle was considered to be the
directed transport of yeast mitochondria into the emerging bud. To
address the molecular requirements for mitochondrial partitioning
during mitosis in yeast, a number of groups initiated various genetic
screens to identify candidate proteins involved in this process
[22,44,61,187,188]. These screens led to the identiﬁcation of most of
the proteins described in the ﬁrst section of this review, but provided
very limited insight into how the mitochondria may be integrated
within the cell cycle machinery, resulting in an uncertain picture of
how the morphology machinery is modulated in response to cell cycle
triggers. Although they did not identify any mutants that resulted in
an absolute block of mitochondrial inheritance, they did identify at
least one mutant that caused a delay. The loss of the type 2C serine/
threonine phosphatase PTC1 (mdm28-1) in yeast results in a delay of
mitochondrial transport into the bud [189], however the mechanisms
and targets of this process have not yet been determined.
There was a recent exception, where Jensen and colleagues
provided a novel link between a Dnm1 and Num1 [190]. Num1 is a
protein associated with the cell cortex initially described to participate
in nuclear migration into the yeast bud [191]. However, the new study
determined that the absence of Num1 also resulted in a defect in
mitochondrial division, showing that Num1 helps facilitate mitochon-
drial ﬁssion [190]. In addition, Num1 interacts with Dnm1, supporting
its role in mitochondrial ﬁssion. The interaction between Dnm1 and
the cortical anchored Num1 also provided a molecular explanation for
the observation that most mitochondria-associated Dnm1 is localized
along the mitochondrial tubules in a polarized manner, on the cell
cortex exposed side [65]. Therefore, this new study determined that
Num1 plays a role both in mitochondrial fragmentation and position-
ing under the cell cortex. Given its established role in mitosis, the
authors also examined the role of Num1 in mitochondrial migration
into the bud. In yeast mitosis, mitochondria must move along actin
cables in order to be delivered into the growing bud. The authors
showed that together Dnm1 and Num1 were required for the
retention of mitochondria within the mother cell. In their absence,
the entire mitochondrial population was found within the daughter
bud in a highly fused state for about 20% of the cells. These dataindicate that the positioning of the Dnm1 ﬁssionmachinery at the bud
tip allowed ongoing ﬁssion events to return a population of
mitochondria back to the mother cell, which appears to ensure the
equal distribution of organelles between the mother and daughter cell
[192]. These studies provide a molecular basis for the cell cycle
regulated changes in mitochondrial morphology and position.
In the mammalian system it hasn't been quite as apparent
whether speciﬁc machinery would be required to ensure the equal
inheritance of mitochondria during mitosis. Given the large number
of mitochondria in most cell types, it is possible that the process
may simply be stochastic. However, microscopy studies reveal that
mitochondria do undergo distinct morphological transitions during
yeast meiosis and sporulation [193,194], processes that do not
involve polarized transport into an emerging bud. In addition, more
recent studies report that the mammalian mitochondria are highly
fused during G1, and shift towards a fragmented phenotype during
G2 and into mitosis [90]. These phenomena suggest that the
machinery governing mitochondrial shape may also be linked to
the cell cycle machinery. To support this idea, one novel mechanism
has shed insight into the dependence of mitochondrial morphology
on the cell cycle phase. During mitosis, rat Drp1 is phosphorylated
on Ser-585 by Cdk1/cyclin B to promote its ﬁssion activity [90].
Although this site is also within the GED domain of Drp1, it is a
different serine residue than that identiﬁed as a target of PKA,
described earlier [91,95]. When expressing the phosphorylation-
deﬁcient mutant S585A, mitotic cells show a dramatic decrease of
the mitochondrial division {Taguchi, 2007 #775}. The presence of
this phosphorylation site in the GTPase effector domain of Drp1
suggested a possible effect on its GTP hydrolysis activity. However,
no change in the GTPase activity of Drp1 was observed in the
phosphorylation-negative mutant or in a phosphomimetic mutant
S585D. Thus, the stimulation of Drp1 ﬁssion activity by phosphor-
ylation of Ser585 could be mediated by an enhanced interaction
with other ﬁssion factors or affect Drp1 self-assembly rate.
Interestingly, this is in contrast to the effects of PKA-mediated
phosphorylation of Drp1 in the GED domain that inhibited its ﬁssion
activity, suggesting that the use of multiple post-translational
modiﬁcations within Drp1 can provide a powerful means to
speciﬁcally modulate its activity.
In summary, many new insights have been generated recently that
illustrate how well integrated the mitochondria must be with the
onset and process of cell division. As may be expected, many of these
mechanisms rely on regulated post-translational modiﬁcations of
proteins like Drp1. As we uncover more of the details that govern
mitochondrial dynamics, it is clear that there will be many more links
to be found between cell cycle and mitochondrial activity. In addition
to the established role of mitochondria in regulating cell death, these
new data may point to exciting possibilities for the use of alternative
mitochondrial targets in drug therapies related to cellular prolifera-
tion in cancer.
3.2. Retrograde signaling
Recent data from a number of groups studying varied topics in
biology, from immunology to development and disease, have found
unexpected links between established signaling pathways and the
mitochondria. So far, the understanding of these links is limited,
where it is often just the identiﬁcation of a signaling protein on the
mitochondrial surface [195,196]. In other examples, the signals
originate from within, through the activity of mitochondrial kinases
[197]. We have included a few examples of recently identiﬁed
signaling axis where it appears that the signal is initiated from the
mitochondrial surface, or utilizes the mitochondria to propagate a
signal. To date, the role of mitochondrial morphology, positioning and
function remains largely unknown with respect to these signaling
pathways. However, it is likely that mitochondrial morphology and
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mitochondria to participate and propagate these signaling events.
3.2.1. Metabolic check points
In addition to the integration of the mitochondria into cellular
signaling cascades, it has also been evident for a number of years that
the mitochondria can also initiate distinct signaling cascades in a
retrograde fashion. One of the most intuitive examples of this is the
observation that low levels of ATP within a cell can inhibit processes
like cell cycle progression. Recently this idea has been taken from an
intuitive phenomenon to a process with a deﬁned molecular pathway.
More speciﬁcally, two new signaling pathways were described in
Drosophila that link mitochondrial dysfunction and cell cycle
checkpoint. A mutation in the cytochrome c oxidase Va (CoVa) causes
a 60% decrease in the cellular ATP production and led to an arrest in
cellular proliferation [198]. Interestingly, this ATP level was still
sufﬁcient to maintain cell survival and differentiation. This difference
in functional requirements for ATP was explained through the speciﬁc
role of AMPK activation. Loss of CoVa led to an increase in AMP level,
resulting in the activation of AMPK and p53. This activated pathway
triggers the selected degradation of Cyclin E, blocking the cell cycle at
the G1/S transition point. This highlights the speciﬁcity of the AMP
signal towards an inhibition of cell cycle progression while not
affecting cellular differentiation and survival.
The same group recently described a second mutation affecting
cell cycle progression, this time in the complex I protein Pdsw [199].
This mutation impaired efﬁcient oxidative phosphorylation, leading
to a signiﬁcant increase in reactive oxygen species (ROS) production.
Importantly, this mutation did not affect the cellular levels of ATP.
The high ROS concentration resulted in the upregulated expression
of Dacapo, an inhibitor of the Cyclin E–CDK2 complex, again
blocking the cell cycle at the G1/S transition point. These data
indicate that mitochondrial metabolism exerts a control on cell cycle
progression through both AMP and ROS levels. These data provide a
much more precise picture of how the metabolic status of the
mitochondria contributes a critical cell cycle check point at the G1/S
transition.
3.2.2. Oxidative signaling
The role of mitochondrial ROS as a signal to block cell cycle
progression is consistent with many previous studies that focus on
ROS as a signaling messenger derived from within the mitochondria
[200]. Mitochondria are the major source of intracellular reactive
oxygen species (ROS). Respiration generates ROS through the
oxidative phosphorylation and ROS are especially produced in
conditions of mitochondrial dysfunction or altered respiration.
Hence, mitochondria are the primary site of oxidative damage in the
cell, a process essential in several human diseases and aging. For
example, the use of a complex I inhibitor rotenone in a mouse model
of Parkinson's disease was an early indicator of how a local increase in
ROS production can lead to disease [201,202]. In addition to steady
state ROS production that may accumulate over time and contribute to
age-related diseases, there are also deﬁned mechanisms that
stimulate more acute ROS production within the mitochondria. The
best example of this involves the activation of the p66Shc protein,
which sensitizes cells to apoptotic stimuli [203]. The current model for
this pathway suggests that cytosolic PKCβ can be activated by
oxidative conditions, which in turn directly phosphorylates cytosolic
p66Shc. Phosphorylated p66Shc is subjected to a conformational
change catalyzed by the peptidyl-prolyl-isomerase Pin1. Isomerized
p66Shc will be translocated into the mitochondrial intermembrane
space where it acts as an oxidoreductase, transferring electrons
directly from cytochrome c to oxygen to generate H2O2. This will
ultimately induce the opening of the mitochondrial permeability
transition pore to ﬁnally promote mitochondrial fragmentation and
cell death [204,205]. This complex mechanism provides an explana-tion for how the generation of an oxidative environment through
mitochondrial ROS signaling can feed back to induce apoptosis and
may help explain the role for p66Shc in the determination of life span
[206].
3.2.3. Mitochondria in immunity
One unanticipated role of mitochondria in cellular signaling was
provided by the discovery that proteins involved in viral immunity
were targeted and anchored within the mitochondrial outer mem-
brane. A number of independent studies identiﬁed a new protein
anchored within the mitochondrial outer membrane, now termed
MAVS (mitochondrial antiviral signaling) [195,207–209]. Together,
these studies revealed that MAVS functions downstream of RIG-I, an
intracellular receptor for viral RNA, and is essential for the activation
of NF-κB and IRF3 pathways in response to viral infection. The N-
terminal CARD-like domain of MAVS likely interacts with CARD-like
domain containing proteins RIG-I and MDA-5. Moreover, additional
data suggested thatMAVS enters into a detergent-resistantmembrane
domain following viral infection, suggesting the modulation of
mitochondrial membrane properties in the transduction of the signal
[195]. Recent studies identiﬁed NLRX1 as another mitochondrial outer
membrane protein contributing to this signaling pathway [210].
NLRX1 is a member of the nucleotide-binding domain proteins
containing leucine rich repeats, a family known to play a critical role
in the cellular surveillance for pathogens. NLRX1 is the only member
of this family to target the mitochondria and was found to interact
with MAVS, where it speciﬁcally inhibits the intracellular antiviral
response. A second study also determined that NLRX1 overexpression
stimulates the production of reactive oxygen species, which may play
a role in its function at the mitochondria [211]. This likely plays a
critical role in the downregulation of the immune response.
Importantly, the reason why MAVS and NLXR1 must be anchored
within the mitochondrial membrane remains unclear. It may reﬂect
somemetabolic or functional check point in this signaling pathway, or
a unique property of the mitochondrial membranes to assemble
speciﬁc complexes. Regardless, we can conclude that the intersection
of the mitochondria along the pathway for NF-κB activation in
immunity is likely to attract a signiﬁcant amount of attention in the
future.
3.2.4. mTOR signaling
The most established retrograde signaling pathway between the
mitochondria and the nucleus is the regulation of mitochondrial
biogenesis in response to nutrient sensing, and the sensing of
mitochondrial dysfunction. The study of this pathway in yeast
identiﬁed a number of retrograde genes (RTG), which are linked to
TOR (target-of-rapamycin) signaling, aging and nutrient sensing [152].
Although many of these mechanisms are rather well established in
yeast model systems, the signaling links between cellular growth and
mitochondrial biogenesis are less well understood in higher eukar-
yotes. It is clear in both systems that the metabolic requirements for
cellular proliferation and growth are extreme. The assembly of new
proteins, lipids, nucleotides and structural elements demands
increased amino acid production and numerous other building blocks.
One of the central regulators of these processes in the context of
cellular growth are the components of the serine-threonine kinase
mTOR (mammalian target of rapamycin) pathway [212,213]. This
pathway is more complex in the mammalian system as it is activated
in the presence of growth factors like insulin. In addition to the
increase in glucose uptake, the PI(3)kinase-dependent activation of
Akt leads to the inhibition of GTP activating proteins (Tsc1 and Tsc2)
for the small GTPase Rheb [214]. This allows the switching of Rheb into
the GTP-bound state, which can then activate mTOR. mTOR then
facilitates amino acid uptake into the cell and can activate protein
synthesis, providing a gateway for the global increase in cellular
nutrients. In this way, the mammalian signals that activate mTOR are
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However, recent evidence may provide a unique intersection
between these twomodels. FKBP38 is amember of the peptidyl-prolyl
cis/trans isomerase (PPIase) family and possesses a unique C-terminal
transmembrane domain anchored in the mitochondrial outer mem-
brane [215,216]. In an unexpected twist, mitochondrial-anchored
FKBP38 interacts directly with mTOR, resulting in the inhibition of its
kinase activity [196]. Upon activation of Rheb to its GTP-bound form,
Rheb competes for mTOR binding with FKBP38, thereby releasing
mTOR from the mitochondrial surface, allowing its cellular activation.
Interestingly, mTOR has just been found to control mitochondrial
oxidative phosphorylation through the expression of the mitochon-
drial transcriptional regulator PGC-1alpha, indicating a complex axis
of signaling that may include the mitochondria at multiple levels
[217]. These studies raise a number of important questions, ﬁrst
among them the curious recruitment of these players to the
mitochondrial surface. Most signaling pathways have depicted these
proteins at the plasma membrane, where the initial receptors are
localized. However, given that a number of the building blocks
required for cell growth are generated within the TCA cycle of the
mitochondria, and the strong evidence for retrograde signaling in
yeast, it may actually make considerable sense to include this
organelle in the signaling pathways. It has been unclear how the
enzymes within the mitochondria are regulated in order to shift their
focus on complete catabolism of glucose to CO2, and move towards
the production of the intermediates required for nucleotide and
amino acid synthesis, including oxaloacetate, β-ketoglutarate, etc
[213]. Perhaps the positioning of this signaling cascade on the
membrane helps to facilitate these types of metabolic shifts.
Alternatively, the functional status of the TCA cycle may represent
another check point for the successful propagation of themTOR signal,
similar to the metabolic check points that function at the G1/S
transition. Future work will continue to explore these complex links
and help to position both anterograde and retrograde mitochondrial
signaling within multiple cellular pathways.
3.2.5. Signaling from within: PINK1
Retrograde signaling, by deﬁnition, implies the involvement of
mitochondrial kinases and other regulatory enzymes capable of
initiating the propagation of a signal from within the mitochondria
to the cell. Instead the examples given above highlight signaling
pathways that have an essential requirement for the mitochondria to
propagate their signals, thereby expanding the deﬁnition of retro-
grade signaling. The presence of a number of uncharacterized
regulatory enzymes associated with the mitochondria suggests that
we have only just begun to understand the extent to which the
mitochondria functions in a signaling capacity, and more importantly,
what these pathways might mean to health and disease. One
important new mitochondrial kinase is the Parkinson-related protein
kinase PINK1 (PTEN-induced kinase 1) [218]. PINK1 is primarily
localized to the mitochondrial inner membrane where its kinase
domain is exposed to the intermembrane space [197]. There is a
consistent cytosolic pool of PINK1 that also has functional importance
[219], however the regulation of these two pools has not yet been
established. To date, two potential mitochondrial targets for PINK1
have emerged, the heat shock protein TRAP1 [220], and the serine
protease Omi/HtrA2 [221]. Interestingly, Omi/HtrA2 is also a Parkin-
son's disease (PD) gene providing support that these proteins may
function on the same pathway [222]. From these recent data, a model
is emerging that posits that the activation of PINK1 leads to the
phosphorylation of TRAP1, which helps to fold any unfolded
intermembrane space proteins, facilitating the mitochondria to
recover from damage. Similarly, the potential phosphorylation of
Omi1/HtrA2 activates the protease activity of this enzyme, leading to
the degradation and increased turnover of unfolded proteins.Although the complete mechanisms remain somewhat speculative,
the emerging picture is that PINK1 helps to maintain mitochondrial
integrity during periods of stress. Consistent with a requirement in
mitochondrial integrity, the loss of PINK1 in mammalian cells leads to
a fragmented mitochondrial reticulum with altered cristae structure
[223]. In an interesting twist, the loss of PINK1 in Drosophila leads to
the opposite morphological phenotype, where the mitochondria
instead become highly fused and enlarged [223–226]. Flies deﬁcient
in PINK1, or another PD related gene that functions downstream of
PINK1, called Parkin, show the degradation of dopaminergic neurons,
harbor a wing muscle defect and cannot ﬂy. Both PINK1 and Parkin
mutant ﬂies show the same morphological change in their mitochon-
dria. Importantly, the inhibition of mitochondrial fusion by the loss of
OPA1 or Mfn rescued the phenotype, demonstrating that the shift
towards the fused state was functionally detrimental for the ﬂy [226].
Furthermore, crossing these ﬂies with a Drp1+/− heterozygote
reduced the residual levels of mitochondrial ﬁssion even further,
which led to complete embryonic lethality [226]. Together, these data
indicated that the residual ﬁssion that did occur in the PINK1 or Parkin
mutants was critical to the survival of the embryo and highlight the
surprising sensitivity of the organism towards changes in the balance
of mitochondrial ﬁssion and fusion.
Why do the ﬂy and human phenotypes in PINK1 deﬁcient cells
appear so dramatically different? One potential explanationmay lie in
an upstream regulator of mitochondrial dynamics called PARL. As
described earlier, PARL is a mitochondrial inner membrane rhomboid
protease [227]. A recent study showed that mammalian PARL is
phosphorylated on at least three sites within the matrix exposed N-
terminus [228]. The kinases and phosphatases that regulate this event
are unknown, however the phosphorylation of PARL regulates a
speciﬁc cleavage event, termed the β-cleavage. Overexpression of the
wild type PARL leads to an increase in mitochondrial fragmentation,
however a mutant form of PARL where the β-cleavage site is removed
does not lead to any change in mitochondrial morphology. The
molecular explanation for this effect on mitochondrial morphology is
not yet clear. Interestingly, the beta-cleavage site is not conserved
within the Drosophila form of PARL, called Rhomboid-7 [227,228].
Depending on how β-cleavage of PARL is regulated under physiolo-
gical conditions, it is possible that the stress induced by PINK1
deﬁciency may lead to β-cleavage of PARL and the inhibition of fusion
in mammalian cells. In contrast, the Drosophila cells lacking PINK1
would not be affected by PARL and instead continue to fuse in an
attempt to rescue the damaged organelles. This speculation serves
only to give an example of how a potentially simple evolutionary
change could lead to alternative outcomes in different genetic models.
Interestingly, the PINK1 target Omi/HtrA2 is also a substrate of PARL
protease activity [229], placing another layer of complexity into the
system. There is an emerging functional triad between PINK1, Omi/
HtrA2 and PARL that will likely have a profound impact on our
understanding of PINK1 function and Parkinson's disease progression.
4. Conclusions
This review has attempted to provide some new insights into how
the plasticity of themitochondria plays a central role in the function of
the organelle, and in relaying diverse cellular signals. We hypothesize
that the enzymes controlling mitochondrial morphology provide a
platform through which cellular signals are transduced within the cell
in order to affect mitochondrial function. These functions include
metabolic regulation, changes in the position of the mitochondria,
partitioning of mitochondria during cell division, and the control of
cell death. The mechanisms that integrate mitochondrial function and
morphology with intracellular demands are rapidly emerging, and
this review has highlighted only a few of them. We are now armed
with an increasing list of new mitochondrial kinases, phosphatases,
ligases and GTPases that may play a role in these pathways, providing
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signaling links can provide new paradigms and drug targets relevant
for the study of many human diseases, including neurodegenerative,
proliferative and immunological, among many others. From its
humble origins as an ancient bacterium, it is now clear that the
mitochondria have evolved into a central player in all aspects of
cellular behavior. The future will undoubtedly provide us with many
more unexpected discoveries that will continue to fuel the current
renaissance in mitochondrial research.
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